Form 4: Avid Bioservices CEO Nicholas Green Reports Stock Transactions
SEC Form 4
Nicholas Green, CEO of Avid Bioservices, reports acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units.
Summary
- Nicholas Green, the President & CEO of Avid Bioservices, Inc., filed a Form 4 detailing changes in beneficial ownership.
- On July 9, 2024, Green acquired 14,400 shares of common stock and performance stock units representing 547,622 shares, and restricted stock units representing 273,811 shares.
- Also on July 9, 2024, Green disposed of 8,826 and 5,574 restricted stock units.
- On July 10, 2024, Green sold 7,657 shares of common stock at a weighted average price of $7.54 per share, with prices ranging from $7.53 to $7.555.
- Following these transactions, Green beneficially owns 212,314 shares of common stock, 1,066,653 performance stock units, and 514,426 restricted stock units.
- The sales were to satisfy tax withholding obligations related to the vesting of restricted stock units and do not represent a discretionary trade.
Sentiment
Score: 6
Explanation: The sentiment is neutral. The filing reflects routine transactions related to stock-based compensation and tax obligations. There is no indication of unusual or concerning activity.
Positives
- The acquisition of performance stock units aligns the CEO's interests with the company's financial performance, incentivizing growth in revenue and pre-tax net income.
Future Outlook
The vesting of performance stock units is contingent upon Avid Bioservices achieving certain fiscal year revenue and adjusted pre-tax net income milestones over three fiscal years, starting April 30, 2025, and continuing through April 30, 2027.
Industry Context
Form 4 filings are routine disclosures for company insiders and provide transparency into their trading activities. These filings are closely watched by investors to gauge management's sentiment and confidence in the company's prospects.
Stakeholder Impact
- The transactions have a limited direct impact on stakeholders, as they primarily reflect internal compensation mechanisms and tax obligations.
- Shareholders may view the vesting of performance stock units positively, as it aligns management's interests with the company's financial performance.
Key Dates
| Date | Description |
|---|---|
| 07/09/2021 | Date of grant for some of the restricted stock units that vest quarterly over four years. |
| 07/09/2022 | Date of grant for some of the restricted stock units that vest quarterly over four years. |
| 07/09/2024 | Date of transactions including acquisition of common stock, performance stock units, and restricted stock units, as well as disposal of restricted stock units. |
| 07/10/2024 | Date of sale of common stock to cover tax obligations. |
| 07/11/2024 | Date of signature for the Form 4 filing. |
| 10/09/2024 | First vesting date for RSUs granted on July 9, 2024. |
| 04/30/2025 | First fiscal year end for performance period related to performance stock units. |
| 04/30/2027 | Last fiscal year end for performance period related to performance stock units. |
Keywords
Avid Bioservices, CDMO, Nicholas Green, Form 4, Stock Transactions, Performance Stock Units, Restricted Stock Units, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.